TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Accuracy in the length of the scleral tunnel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: lateral incomitance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-day mortality odds
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative vaginal length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGI-I questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adjustment process
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: adherence to instructions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Resolution of microerosions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RVP resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of physical education class time spent engaged in moderate to vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in OLS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHI (Dizziness Handicap Inventory)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COPM satisfaction (Canadian Occupational Performance Measure)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Palmer pinch strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean rescue artificial tear use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median rescue artificial tear use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of users of large amounts of rescue artificial tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean physical health score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: gingivitis levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1500 m performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in malondialdehyde (MDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increase in glutathione peroxidase (GSH-Px)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Knowledge of target cohort eligibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Understanding of HPV infection and vaccine use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Community acceptance of HPV vaccine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: hospice length of stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge regarding hospice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: preference for hospice care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EQ-5D-3L VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain VAS
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: portrait memory test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: POST with numeric rating scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Time on mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vigorous physical activity (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedentary activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: higher odds of adequate sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: App acceptability ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: enhanced memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: confident performance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: knowledge of diabetic retinopathy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: neck disability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low disease activity (LDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication possession ratio (MPR)
Endpoint domain: Resource use
Primary endpoint: Risk of ADHD
Endpoint domain: Adverse events/effects
Primary endpoint: Invagination of soft tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median thickness of the mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for additional GBR
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Probability of successful downstaging to Milan criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of LT at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Post‐LT survival at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Coefficient of variation for sensor glucose at 6 a.m.
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coefficient of variation for mean sensor glucose at 5–6 a.m.
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall basal insulin dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in CAD (mean difference in days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First attempt success rate of arterial cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall cannulation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Occurrence rate of hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery rate of NK cells function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complications rate (fistula and glandular dehiscence)
Endpoint domain: Adverse events/effects
Primary endpoint: Concordance of telecytology onsite assessment with final cytologic assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of onsite interpretation errors by inexperienced cytopathologists
Endpoint domain: Adverse events/effects
Primary endpoint: fear scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Exposure to agrochemical health risks
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of positive cytology from brushings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of positive cytology from washings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall diagnostic yield of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔSBP15‐60M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔSBP6‐24H
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RTI-associated hospital admission
Endpoint domain: Mortality/survival
Primary endpoint: discharge survival
Endpoint domain: Mortality/survival
Primary endpoint: neurological recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: VNRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain perception during injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleepiness mean score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Alertness mean score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: minute volume of ventilation (MV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Perceived risk of criminality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Client change language
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: tolerability of VP250
Endpoint domain: Adverse events/effects
Primary endpoint: mean convalescence period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time for complete wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: structural damage progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follow-up physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement of smell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 AUC0‐3h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: BCG skin reaction size and characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: B12 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Preventing increase in child mental health problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved perceived parental control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: clinical pregnancy rates per cycle
Endpoint domain: Mortality/survival
Primary endpoint: Disability measured by the Nine-Hole Peg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MoCA scores after 6 treatments of ECT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interstitial Extracellular Volume (iECV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Request for urgent review
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor inhibition rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Average tumor mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: risk of new vertebral fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: VT recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 12-month retention
Endpoint domain: Resource use
Primary endpoint: cardiovascular death, stroke, or myocardial infarction (MI)
Endpoint domain: Mortality/survival
Primary endpoint: Average duration of crying/fussing episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency to first and second nap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lifetime PTSD
Endpoint domain: Adverse events/effects
Primary endpoint: depression
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of opioid withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of opioid withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: persistent disabling condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morning diastolic blood pressure (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Modified Cormack-Lehane grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased basophil sensitivity to peanut
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composite endpoint of death or need for orthotopic heart transplant (OHT) or left ventricular assist device (LVAD) at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: PDA closure rate at 1 week after randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPD incidence or death
Endpoint domain: Mortality/survival
Primary endpoint: Time consumed on wayfinding tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking distance to find the correct destination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain observation during enucleation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration–time curve ratio (AUCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytochrome P450 (CYP) 3A inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to adequate anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCEA boluses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in respiratory infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in wheezing episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean comfort scores of preterm infants
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sagittal changes of circummaxillary sutures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of infection‐associated adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Lymph node dissection efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Compliance with CARD™ components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitudes towards CARD™
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Transition to healthy gingival case status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total menopausal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for improvement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: pain scores (PRI, PPI, VAS, ODI, FABQ, FFD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schober test distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in body fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of LGD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Neoplastic progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Jefferson Scale of Empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Kogan's Attitudes Toward Old People Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge About Aging
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hyperkalemia rate
Endpoint domain: Adverse events/effects
Primary endpoint: Specificity of serologic tests for IgM and IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adherence to follow-up instructions
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Recall of red flags
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: CFQ‐R‐Respiratory Symptoms Scores (CFQ‐R‐RSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptance of sublingual dexmedetomidine route
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anxiety scores during local anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔΔQTcF effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: degree of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VAS scores for pain in DH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean vertical bone gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean bone gain percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular depth of focus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of type I IFN gene signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mesial and distal papilla height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recession of buccal marginal gingiva
Endpoint domain: Adverse events/effects
Primary endpoint: 24-h BP control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Histological yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-pass diagnostic yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: school climate
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: TTFields dose delivery to the tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient usage or time on treatment
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Inhibition of Colletotrichum sp. growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suppression of anthracnose development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in chilli seed viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone marrow fibrosis improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variant allele frequency reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in ONSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ADAS-Cog13 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: CDR Sum of Boxes (CDR-SOB) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: FAQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean EDSS reduction after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in vertical pocket depth (VPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration of complete healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regional insulin action
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: first and recurrent ischemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Quick DASH score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thigh pain VAS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MuRF‐1 mRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PLP intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICI changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICF changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBC clotted sample rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBC rejection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total sleep quality score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Unplanned emergency department/clinic visits due to renal colic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: decrease in aggressive responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported reactive aggression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: increase in late positive potential amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glaucoma surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in central macular thickness (CMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in ETDRS letter score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in MSQ total scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvement in MIDAS total scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 2-year rates of death or HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: 30-day PASP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes